Deepak Teotia Fiza

Liposomal Nanocarriers for Tuberculosis Therapy: Design, Challenges, and Clinical Translation

AbstractTuberculosis (TB) remains one of the leading infectious causes of death globally, withMycobacterium tuberculosis infecting an estimated 10.6 million people in 2022 and claiming 1.3million lives. The emergence of multidrug-resistant (MDR-TB) and extensively drug-resistant(...